Founded in 2007, by Rudolf Jaenisch, Fate Therapeutics corporate headquarters are located in San Diego, California. It also has a subsidiary in Ottawa, Canada.
Fate Therapeutics is an innovative biotechnology company developing novel stem cell modulators and biologic or small molecule compounds that guide cell fate. Fate Therapeutics’ lead clinical program, ProHema, consists of pharmacologically-enhanced hematopoietic stem cells (HSCs) designed to improve HSC support during the normal course of a stem cell transplant for the treatment of patients with hematologic malignancies. [Read more…]







